MENU
+Compare
DXCM
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$86.33
Change
+$1.65 (+1.95%)
Capitalization
53.47B

DXCM DexCom Forecast, Technical & Fundamental Analysis

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients... Show more

DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DXCM with price predictions
Jun 27, 2025

DXCM sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for DXCM moved above the 200-day moving average on June 09, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 26, 2025. You may want to consider a long position or call options on DXCM as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DXCM just turned positive on June 27, 2025. Looking at past instances where DXCM's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

DXCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 248 cases where DXCM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DXCM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DXCM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (25.707) is normal, around the industry mean (24.463). P/E Ratio (106.108) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (2.565) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (16.207) is also within normal values, averaging (43.062).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DXCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

DXCM is expected to report earnings to rise 38.75% to 44 cents per share on July 24

DexCom DXCM Stock Earnings Reports
Q2'25
Est.
$0.44
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.07
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.04
The last earnings report on May 01 showed earnings per share of 31 cents, missing the estimate of 33 cents. With 4.63M shares outstanding, the current market capitalization sits at 53.47B.
A.I. Advisor
published General Information

General Information

a maker of medical devices and glucose monitoring systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
6340 Sequence Drive
Phone
+1 858 200-0200
Employees
9600
Web
https://www.dexcom.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FTIF21.470.09
+0.42%
First Trust Bloomberg Infl Snstv Eq ETF
BLCN22.820.05
+0.22%
Siren Nasdaq NexGen Economy ETF
JAAA50.750.03
+0.06%
Janus Henderson AAA CLO ETF
THNQ54.58N/A
N/A
Robo Global® Artificial Intelligence ETF
IBDY25.80-0.02
-0.08%
iShares iBonds Dec 2033 Term Corp ETF

DXCM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with RMD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then RMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
+1.95%
RMD - DXCM
35%
Loosely correlated
-0.41%
BAX - DXCM
35%
Loosely correlated
-0.36%
IRMD - DXCM
34%
Loosely correlated
+0.21%
MDT - DXCM
33%
Loosely correlated
+0.64%
PEN - DXCM
33%
Loosely correlated
N/A
More